
UCLA Brain Cancer Studies Find Immune Gains and Resistance
UCLA brain cancer researchers reported two contrasting glioblastoma findings on October 13, 2026. A 63-patient study showed greater immune activity with two checkpoint drugs, while a mouse model reproduced resistance seen in human tumors. Together, the findings provide new information about immunotherapy responses without establishing a definitive survival benefit.


















